Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Phase II results with T-cell receptor peptides in RA promising

Nov. 20, 1997

GL-701 shows significant steroid-sparing effects in women with active SLE

Nov. 20, 1997

Synvisc introduced in U.S.

Nov. 20, 1997

Preliminary phase III data presented on celecoxib at arthritis symposium

Nov. 20, 1997

Enbrel phase III and long-term safety data presented at rheumatology meeting

Nov. 20, 1997

New VCAM-1 inhibitor isolated from marine sponge

Nov. 19, 1997

rhIL-11 effective in rats with adjuvant arthritis

Nov. 19, 1997

rhIL-10 evaluated for safety and efficacy in RA patients

Nov. 19, 1997

Complement activation inhibitors prepared at U of Pennsylvania

Nov. 19, 1997

Second-generation, highly selective COX-2 inhibitors developed at Merck

Nov. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...